ChemMedChem
 | |
| Discipline | Chemistry |
|---|---|
| Language | English |
| Edited by | David Peralta |
| Publication details | |
| History | 2006–present |
| Publisher | Wiley-VCH on behalf of Chemistry Europe |
| Frequency | biweekly |
| 3.124 (2019) | |
| Standard abbreviations | |
| ISO 4 | ChemMedChem |
| Indexing | |
| CODEN | CHEMGX |
| ISSN | 1860-7179 (print) 1860-7187 (web) |
| Links | |
ChemMedChem is a monthly peer-reviewed medicinal chemistry journal. It is co-owned by the 16 European chemical society members of Chemistry Europe and is published by Wiley-VCH. [1] In addition to original research in the form of full papers and shorter communications, ChemMedChem contains review-type articles (reviews, minireviews, patent reviews, essays, highlights) as well as occasional book reviews and conference reports.
Topics covered in ChemMedChem include drug design, development and delivery, molecular modeling, combinatorial chemistry, drug target validation, lead generation, ADMET studies, and as of 2017, nanomedicine (including targeted drug delivery, theranostics, and nanodrugs).
The first volume was published at the beginning of 2006 under the two founding chemical societies, the German Chemical Society (GDCh) and the Italian Chemical Society (SCI). Since then, 14 additional chemical societies have joined in co-ownership of the journal. ChemMedChem is a sister publication to other scientific journals published by Wiley-VCH, including Angewandte Chemie, ChemBioChem, ChemPhysChem, ChemSusChem, ChemCatChem, and ChemistryViews.
The Editorial Board is chaired by Karl-Heinz Altmann (ETH Zürich), Sangyong Jon (KAIST), and Antonello Mai (Università degli Studi di Roma "La Sapienza").
According to the Journal Citation Reports, the journal has an impact factor of 3.124 (2019).[2]
References
- ^ http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1860-7187
- ^ "ChemMedChem". 2019 Journal Citation Reports. Web of Science (Science ed.). Thomson Reuters. 2020.